Diabetologia ( IF 8.2 ) Pub Date : 2021-10-16 , DOI: 10.1007/s00125-021-05583-4 Aaron Jesuthasan 1 , Sviatlana Zhyzhneuskaya 1 , Carl Peters 1 , Alison C Barnes 2 , Kieren G Hollingsworth 1 , Naveed Sattar 3 , Michael E J Lean 4 , Roy Taylor 1 , Ahmad H Al-Mrabeh 1, 5
Aims/hypothesis
Type 2 diabetes confers a greater relative increase in CVD risk in women compared with men. We examined sex differences in intraorgan fat and hepatic VLDL1-triacylglycerol (VLDL1-TG) export before and after major dietary weight loss.
Methods
A group with type 2 diabetes (n = 64, 30 male/34 female) and a group of healthy individuals (n = 25, 13 male/12 female) were studied. Intraorgan and visceral fat were quantified by magnetic resonance and VLDL1-TG export by intralipid infusion techniques.
Results
Triacylglycerol content of the liver and pancreas was elevated in people with diabetes with no sex differences (liver 16.4% [9.3–25.0%] in women vs 11.9% [7.0–23.1%] in men, p = 0.57, and pancreas 8.3 ± 0.5% vs 8.5 ± 0.4%, p = 0.83, respectively). In the absence of diabetes, fat levels in both organs were lower in women than men (1.0% [0.9–1.7%] vs 4.5% [1.9–8.0%], p = 0.005, and 4.7 ± 0.4% vs 7.6 ± 0.5%, p< 0.0001, respectively). Women with diabetes had higher hepatic VLDL1-TG production rate and plasma VLDL1-TG than healthy women (559.3 ± 32.9 vs 403.2 ± 45.7 mg kg−1 day−1, p = 0.01, and 0.45 [0.26–0.77] vs 0.25 [0.13–0.33] mmol/l, p = 0.02), whereas there were no differences in men (548.8 ± 39.8 vs 506.7 ± 29.2 mg kg−1 day−1, p = 0.34, and 0.72 [0.53–1.15] vs 0.50 [0.32–0.68] mmol/l, p = 0.26). Weight loss decreased intraorgan fat and VLDL1-TG production rates regardless of sex, and these changes were accompanied by similar rates of diabetes remission (65.4% vs 71.0%) and CVD risk reduction (59.8% vs 41.5%) in women and men, respectively.
Conclusions/interpretation
In type 2 diabetes, women have liver and pancreas fat levels as high as those of men, associated with raised hepatic VLDL1-TG production rates. Dynamics of triacylglycerol turnover differ between sexes in type 2 diabetes and following weight loss. These changes may contribute to the disproportionately raised cardiovascular risk of women with diabetes.
Graphical abstract
中文翻译:
器官内脂肪水平和肝脏脂质代谢的性别差异:饮食减肥后对心血管健康和2型糖尿病缓解的影响
目标/假设
与男性相比,2 型糖尿病导致女性 CVD 风险相对增加更大。我们检查了主要饮食减肥前后器官内脂肪和肝脏 VLDL1-三酰甘油 (VLDL1-TG) 输出的性别差异。
方法
对一组 2 型糖尿病患者(n = 64,30 名男性/34 名女性)和一组健康个体(n = 25,13 名男性/12 名女性)进行了研究。通过磁共振定量器官内和内脏脂肪,并通过脂肪注射技术输出 VLDL1-TG。
结果
糖尿病患者肝脏和胰腺的三酰甘油含量升高,无性别差异(女性肝脏为 16.4% [9.3–25.0%],男性为 11.9% [7.0–23.1%],p = 0.57,胰腺为 8.3 ± 0.5 % 与 8.5 ± 0.4%,分别为p = 0.83)。在没有糖尿病的情况下,女性两个器官的脂肪水平均低于男性(1.0% [0.9–1.7%] vs 4.5% [1.9–8.0%],p = 0.005,以及 4.7 ± 0.4% vs 7.6 ± 0.5%) ,p < 0.0001,分别)。糖尿病女性的肝脏 VLDL1-TG 生成率和血浆 VLDL1-TG 高于健康女性(559.3 ± 32.9 vs 403.2 ± 45.7 mg kg −1 day −1,p = 0.01,以及 0.45 [0.26–0.77] vs 0.25 [0.13) –0.33] mmol/l,p = 0.02),而男性则没有差异(548.8 ± 39.8 vs 506.7 ± 29.2 mg kg −1 day −1,p = 0.34,以及 0.72 [0.53–1.15] vs 0.50 [0.32 –0.68] 毫摩尔/升,p = 0.26)。无论性别如何,体重减轻都会降低器官内脂肪和 VLDL1-TG 生成率,这些变化伴随着女性和男性糖尿病缓解率(65.4% vs 71.0%)和 CVD 风险降低率(59.8% vs 41.5%)相似。 。
结论/解释
在 2 型糖尿病中,女性的肝脏和胰腺脂肪水平与男性一样高,这与肝脏 VLDL1-TG 生成率升高有关。在 2 型糖尿病和减肥后,三酰甘油周转的动态在性别之间存在差异。这些变化可能会导致女性糖尿病患者的心血管风险异常升高。